NCT01792791

Brief Summary

Arthritis is the nation's most common cause of disability. An estimated 50 million U.S. adults (about 1 in 5) report doctor-diagnosed arthritis. Twenty three million U.S. adults of working age (18-64 years) have arthritis; and in this age group arthritis-attributable work limitations affect about 1 in 3 people. An estimated 12% of all patients seeking intervention for symptomatic arthritis have an etiology of previous trauma to the involved joint. The purpose of this study is to examine these inflammatory compounds in the joint fluid (synovial fluid), the joint lining (synovium), and in blood among subjects with isolated intra-articular fractures. The hypothesis is that early levels of intra-articular inflammation and markers of joint tissue degeneration following articular fracture in the human knee are predictive of the development of PTA (Post Traumatic Arthritis). Early levels of intra-articular inflammation and markers of joint tissue degeneration identified from human knee joints following articular injury are predictive of the development of PTA in the mouse knee. Samples of blood, urine and synovial fluid will be taken at the spanning frame surgery and only synovial fluid at the ORIF (Open Reduction Internal Fixation)surgery. Two MRIs (Magnetic Resonance Imaging) will be part of this study at 4 weeks and 18 months.Participants will complete a set of questionnaires(KOOS: Knee Injury and Osteoarthritis Outcome Score) at 4 weeks and 18 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

October 25, 2012

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 15, 2013

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

December 19, 2016

Status Verified

August 1, 2015

Enrollment Period

4.1 years

First QC Date

October 25, 2012

Last Update Submit

December 16, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Markers of joint tissue degeneration following articular fracture

    Tissue samples will be collected at the time of surgery and they will be taken to Duke Basic Science lab where they will be analyzed.

    18 months after Injury

Secondary Outcomes (1)

  • KOOS questionnaire

    Participants will complete this questionnaire at the 18 month follow up

Other Outcomes (1)

  • Change from baseline at 18 months of the extracellular matrix and morphology of knee cartilage using MRI

    Between week 2 and 6 and at 18 months after definitive fixation

Study Arms (1)

Single Arm

Procedure: Tissue sample collection at the time of surgery

Interventions

Spanning surgery * A blood sample (32.5 ml) * joint aspirate (removal of synovial fluid) from both knees * urine sample ORIF surgery * Joint aspirate (removal of synovial fluid) from both knees * A blood sample (32.5 ml) * Urine Sample If patients only require one surgery, sample will be collected only once.

Single Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adults that are at least 18 years old and had a unilateral closed intra articular fracture of the knee that requires surgery.

You may qualify if:

  • Subjects will be adult patients (over 18 years old)
  • Patients must present with a unilateral closed intra-articular fracture of the knee.

You may not qualify if:

  • Pre-existing arthritis in the injured or contra-lateral knee,
  • Previous total knee replacement
  • Active joint infection
  • Pathologic fracture
  • Active inflammatory arthritis
  • Open fracture of the involved knee
  • Contra-lateral knee injury
  • HIV infection (if previously known)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27707, United States

Location

MeSH Terms

Conditions

Arthritis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Study Officials

  • Steven Olson, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2012

First Posted

February 15, 2013

Study Start

October 1, 2012

Primary Completion

November 1, 2016

Study Completion

December 1, 2016

Last Updated

December 19, 2016

Record last verified: 2015-08

Locations